1. Home
  2. HSCS vs WLGS Comparison

HSCS vs WLGS Comparison

Compare HSCS & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSCS
  • WLGS
  • Stock Information
  • Founded
  • HSCS 2007
  • WLGS 1981
  • Country
  • HSCS United States
  • WLGS Hong Kong
  • Employees
  • HSCS N/A
  • WLGS N/A
  • Industry
  • HSCS Medical Specialities
  • WLGS Engineering & Construction
  • Sector
  • HSCS Health Care
  • WLGS Consumer Discretionary
  • Exchange
  • HSCS Nasdaq
  • WLGS Nasdaq
  • Market Cap
  • HSCS 3.7M
  • WLGS 4.4M
  • IPO Year
  • HSCS 2022
  • WLGS 2023
  • Fundamental
  • Price
  • HSCS $3.83
  • WLGS $0.04
  • Analyst Decision
  • HSCS Strong Buy
  • WLGS
  • Analyst Count
  • HSCS 2
  • WLGS 0
  • Target Price
  • HSCS $13.00
  • WLGS N/A
  • AVG Volume (30 Days)
  • HSCS 68.9K
  • WLGS 40.2M
  • Earning Date
  • HSCS 07-28-2025
  • WLGS 08-14-2025
  • Dividend Yield
  • HSCS N/A
  • WLGS N/A
  • EPS Growth
  • HSCS N/A
  • WLGS N/A
  • EPS
  • HSCS N/A
  • WLGS N/A
  • Revenue
  • HSCS N/A
  • WLGS $3,951,649.00
  • Revenue This Year
  • HSCS N/A
  • WLGS N/A
  • Revenue Next Year
  • HSCS N/A
  • WLGS N/A
  • P/E Ratio
  • HSCS N/A
  • WLGS N/A
  • Revenue Growth
  • HSCS 261.17
  • WLGS N/A
  • 52 Week Low
  • HSCS $2.36
  • WLGS $0.03
  • 52 Week High
  • HSCS $5.44
  • WLGS $9.66
  • Technical
  • Relative Strength Index (RSI)
  • HSCS 53.87
  • WLGS 24.41
  • Support Level
  • HSCS $3.63
  • WLGS $0.03
  • Resistance Level
  • HSCS $4.03
  • WLGS $0.05
  • Average True Range (ATR)
  • HSCS 0.29
  • WLGS 0.01
  • MACD
  • HSCS 0.00
  • WLGS 0.01
  • Stochastic Oscillator
  • HSCS 42.50
  • WLGS 8.52

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.

Share on Social Networks: